|
|
|
|
| Advertisement |
 |
|
|
| Top Story |
 |
|
Biosimilars Battles Heat Up |
With the rise in industry programs for developing biosimilars, tensions are high as innovator firms back strategies that appear designed to delay competition. Jill Wechsler reports
… /Read more/ |
|
|
| Advertisement |
Seeking new ways to engage employees? Check out tips from award-winning recognition provider, Rymax.
 Download now
|
|
| Advertisement |
The world is larger than you think - Don't get lost
Cultural insight the key to doing business in a globalized world. Become a global business insider with Pharma Reports, a series of PDF-format reports detailing the latest market conditions and opportunities in more than 10 countries.
 Explore now
|
|
| Advertisement |
Don't let your campaign fall apart
Strategic product management is the glue holding an operation together. This Pharmaceutical Executive handbook is your go-to guide for effective and profitable product management.
 Read more
|
|
|
| Advertisement |
A panel discussion with insights from emerging biopharma executives
Wednesday, October 3, 2018 at 11am EDT
 Register now
|
|
|
|
/ September 25–26: Finance and Accounting for Bioscience Companies / |
|
Boston, MA |
|
/ September 25–26: 4th Annual Bio/Pharmaceutical Product Launch Summit / |
|
Cambridge, MA |
|
/ September 27: 3rd Edition Drug Pricing Transparency Congress / |
|
Philadelphia, PA |
|
/ November 14–15: Commercial Data Insights 2018 / |
|
Philadelphia, PA |
|
/ November 14–15: 5th Annual Global Compliance Congress for Life Sciences / |
|
London, UK |
|
/ November 28–29: Compliant Patient Support Programs Summit / |
|
Chicago, IL |
|
/ December 3–4: Digital Therapeutics
/ |
|
New York, NY |
|
/ December 4–5: Bio/Pharma Compliance Congress on Non-Promotional Activities
/ |
|
Philadelphia, PA |
|
/ December 4–5: Managed Markets Compliance Congress
2018
/ |
|
Philadelphia, PA |
|
/ December 12: Specialty Product Data Strategies / |
|
Philadelphia, PA |
|
|
|
| Advertisement |
 |
|
|
| Advertisement |
Leverage Your Data to Meet Rising Expectations within Life Sciences
On Demand
 Learn more
|
|
|
| Industry update |
| //
Jacqualyn ("Jackie") Fouse, Ph.D. was named as the next Chief Executive Officer of Agios Pharmaceuticals (Cambridge, MA), effective February 1, 2019. Current CEO David Schenkein, M.D. will transition to the role of Executive Chairman of the Board of Directors and serve as a member of the Board's Science & Technology Committee.
//
resTORbio (Boston, MA) appointed Meredith Manning as Chief Commercial Officer.
//
Deciphera Pharmaceuticals (Waltham, MA) appointed Daniel C. Martin as Chief Commercial Officer.
//
Codiak BioSciences (Cambridge, MA) announced the appointment of Robert M. Brenner, M.D. as Executive Vice President and Head of Research and Development.
//
Manuel Aivado, M.D, Ph.D, was named President and Chief Executive Officer of Aileron Therapeutics (Watertown, MA).
//
Achillion Pharmaceuticals (New Haven, CT) announced the appointment of Paul Firuta to the position of Executive Vice President and Chief Operating Officer.
//
Pfenex (San Diego, CA) announced that Dr. Shawn A. Scranton, will be joining the company as Chief Operating Officer, effective October 1, 2018.
//
|
|
|
